TFE3, transcription factor binding to IGHM enhancer 3, 7030
N. diseases: 118; N. variants: 0
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
disease | Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | Neoplastic Process | 134 | 0.300 | None | 0 | |||||||||
|
phenotype | Cell or Molecular Dysfunction | 151 | 0.100 | None | 0 | ||||||||||
|
disease | Neoplasms | Neoplastic Process | 65 | 0.010 | None | < 0.001 | 1 | 2018 | 2018 | ||||||
|
disease | Neoplasms | Neoplastic Process | 77 | 0.010 | None | < 0.001 | 1 | 2019 | 2019 | ||||||
|
disease | Neoplasms | Neoplastic Process | 33 | 0.010 | None | < 0.001 | 1 | 2019 | 2019 | ||||||
|
disease | Neoplasms; Endocrine System Diseases | Neoplastic Process | 6 | 0.010 | None | < 0.001 | 1 | 2017 | 2017 | ||||||
|
disease | Neoplasms | Neoplastic Process | 78 | 0.010 | None | < 0.001 | 1 | 2019 | 2019 | ||||||
|
disease | Neoplasms | Neoplastic Process | 325 | 30 | 0.010 | None | < 0.001 | 1 | 2014 | 2014 | |||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Neoplasms | Neoplastic Process | 6385 | 327 | 0.030 | None | 0.667 | 3 | 2011 | 2014 | |||||
|
disease | Neoplasms | Neoplastic Process | 26 | 0.060 | None | 0.833 | 6 | 2013 | 2020 | ||||||
|
disease | Neoplasms | Neoplastic Process | 26 | 0.060 | None | 0.833 | 6 | 2013 | 2020 | ||||||
|
group | Neoplasms | Neoplastic Process | 8621 | 1641 | 0.100 | None | 0.867 | 15 | 2001 | 2019 | |||||
|
phenotype | Pathological Conditions, Signs and Symptoms; Neoplasms | Neoplastic Process | 6243 | 355 | 0.080 | None | 0.875 | 8 | 2010 | 2020 | |||||
|
disease | Neoplasms | Neoplastic Process | 29 | 0.080 | None | 0.875 | 8 | 2013 | 2020 | ||||||
|
disease | Neoplasms | Neoplastic Process | 36 | 4 | 0.400 | None | 0.909 | 11 | 2013 | 2020 | |||||
|
group | Neoplasms | Neoplastic Process | 8221 | 1374 | 0.100 | None | 0.909 | 11 | 2001 | 2019 | |||||
|
group | Neoplasms | Neoplastic Process | 2462 | 103 | 0.100 | None | 0.917 | 12 | 2002 | 2017 | |||||
|
disease | Neoplastic Process | 264 | 3 | 0.100 | None | 0.929 | 14 | 2001 | 2019 | ||||||
|
group | Neoplasms | Neoplastic Process | 10161 | 1644 | 0.100 | None | 0.946 | 74 | 2001 | 2020 | |||||
|
group | Neoplasms | Neoplastic Process | 31 | 0.100 | None | 0.964 | 28 | 2008 | 2019 | ||||||
|
disease | Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | Neoplastic Process | 33 | 0.400 | None | 0.969 | 32 | 2010 | 2019 | ||||||
|
disease | Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | Neoplastic Process | 2084 | 288 | 0.500 | None | 0.983 | 120 | 1996 | 2020 | |||||
|
disease | Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | Neoplastic Process | 2346 | 222 | 0.400 | None | 0.988 | 82 | 2001 | 2020 | |||||
|
disease | Neoplasms | Neoplastic Process | 61 | 0.400 | None | 1.000 | 48 | 2001 | 2020 | ||||||
|
disease | Neoplasms | Neoplastic Process | 30 | 0.100 | None | 1.000 | 20 | 2001 | 2020 |